Job title: Chief Scientific Officer
Dr. Lawrence S. Lamb is our Executive Vice President and Chief Scientific Officer as of January 2019. He is a co-founder of Incysus and is recognized as a leader in the field of gamma-delta (γδ) T cells. He was previously a Clinical Laboratory Immunologist and Professor of Medicine at the University of Alabama at Birmingham (UAB) specializing in transplantation immunology. He also held appointments in Pathology and Pediatrics and is board-certified by the Oncology Nursing Certification Corporation for Advanced Practice in Oncology Nursing (AOCNS). Dr. Lamb concurrently held the position as the Director of the UAB Cell Therapy Laboratory in the Section of Bone Marrow Transplant and Cellular Therapy.
Panel Discussion: Comparing the Activities of Different γδ T Subsets: Which one is best? 10:30 am
• Outlining the advantages of the γδ 2 subset and their response to phosphoantigens • Discussing the issues of repeated antigen stimulation with delta 2 and loss of response • Exploring the potential of the tissue resident delta 1 subset to treat solid tumorsRead more
day: Day One
Either/Or or Both/And – The Delta One vs. Delta Two Conundrum 10:00 am
• Current therapeutic γδ T cell options from industry and academic and justification of selected γδ T phenotype • Is one better than the other or application-dependent • Towards a rational strategy for choice of phenotype for cancer therapyRead more
day: Day One